Pages that link to "Q84560485"
Jump to navigation
Jump to search
The following pages link to T-cell therapy at the threshold (Q84560485):
Displaying 29 items.
- Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? (Q27002575) (← links)
- Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy (Q34334598) (← links)
- Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy (Q34431441) (← links)
- Improving the safety of cell therapy with the TK-suicide gene (Q34477411) (← links)
- Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity (Q34592273) (← links)
- Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies. (Q34649397) (← links)
- Adoptive cellular immunotherapy in metastatic renal cell carcinoma: a systematic review and meta-analysis (Q34717795) (← links)
- Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes (Q35144751) (← links)
- Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. (Q35567765) (← links)
- Engager T cells: a new class of antigen-specific T cells that redirect bystander T cells (Q35591391) (← links)
- Building better monoclonal antibody-based therapeutics. (Q35817552) (← links)
- The nitric oxide radical scavenger carboxy-PTIO reduces the immunosuppressive activity of myeloid-derived suppressor cells and potentiates the antitumor activity of adoptive cytotoxic T lymphocyte immunotherapy (Q36060268) (← links)
- Depletion of B220(+)NK1.1(+) cells enhances the rejection of established melanoma by tumor-specific CD4(+) T cells (Q36060315) (← links)
- Genetically modified T-cell therapy for osteosarcoma (Q36198232) (← links)
- T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma (Q36494634) (← links)
- Profound impairment of adaptive immune responses by alkylating chemotherapy (Q36922577) (← links)
- Collapse of the tumor stroma is triggered by IL-12 induction of Fas. (Q36984473) (← links)
- Koch Institute Symposium on Cancer Immunology and Immunotherapy (Q37500940) (← links)
- Adoptive immunotherapy for cancer or viruses (Q38178359) (← links)
- Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir (Q38777005) (← links)
- Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells (Q38865261) (← links)
- Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells (Q38955075) (← links)
- An efficient large-scale retroviral transduction method involving preloading the vector into a RetroNectin-coated bag with low-temperature shaking (Q39031463) (← links)
- Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma (Q39174520) (← links)
- Delivering safer immunotherapies for cancer (Q39330984) (← links)
- Immune Mechanisms Are Major Players in Cancer (Q42534814) (← links)
- Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy (Q45870945) (← links)
- Next frontiers in CAR T-cell therapy (Q46848787) (← links)
- CAR-T field booms as next-generation platforms attract big players (Q50046256) (← links)